The Effect of Mitomycin C on Reducing Endometrial Fibrosis for Intrauterine Adhesion

Abstract

Departmental sources Background: Intrauterine adhesion (IUA) is a common reproductive system disease in women, characterized by endometrial stromal cell proliferation, increasing fibroblasts and increasing extracellular matrix secretion. The purpose of this study was to investigate the effect of mitomycin C on reducing endometrial fibrosis for IUA. Material/Methods: Firstly, a rat IUA model was constructed by intrauterine mechanical injury. The endometrial stromal cells and fibroblasts were isolated and treated with mitomycin C. After that, Cell Counting Kit-8 (CCK-8) assay was used to investigate the endometrial stromal cell viability. Furthermore, cell cycle and apoptosis assays of endometrial stromal cells and fibroblasts were performed, respectively. Finally, the cell viability of human endometrial cells or human uterus adhesion fibroblasts treated with mitomycin C was determined using CCK-8 assay with or without estradiol. Results: Endometrial stromal cells were isolated from a rat IUA model. Cell cycle assay results showed that mitomycin C inhibited cell viability and promoted G1 cell cycle arrest and apoptosis in rat IUA endometrial stromal cells. Fibroblasts were also isolated from the rat IUA model. We found that mitomycin C inhibited the synthesis and secretion of collagen type I by western blotting analysis. Furthermore, mitomycin C promoted G1 cell cycle arrest and apoptosis in IUA rat uterine fibroblasts. We found that estradiol decreased the inhibitory effects of cell viability of human endometrial cells and human uterus adhesion fibroblasts by mitomycin C. Conclusions: Our findings revealed that mitomycin C could reduce endometrial fibrosis for intrauterine adhesion.

ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts

“… 24 Type 1 collagen secretion in rat uterine fibroblasts was significantly lowered by treatment with 5 µg/mL MMC for 48 hours. 25 Our experiments demonstrated significantly lowered collagen contraction with shorter SB and MMC treatment durations compared to those studies. Since the collagen lattice functions as an in vitro 3D tissue mimetic, differences in HTCF-mediated contraction may offer insight into HTCF scarring activity in vivo.…”

Genetically engineered FGF1-sericin hydrogel material treats intrauterine adhesion and restores fertility in rat

“…In the wound, the cells lose contact and the production of growth factors and cytokines occurs [ 47 ]. Fibroblast migration regulates cell proliferation and collagen regeneration and is a key step in cell repair [ 48 ], while sericin increases the number of fibroblasts entering the damaged area [ 49 ]. At present, it is believed that the main cause of endometrial fibrosis is the abnormal migration and proliferation of uterine epithelial cells and stromal cells, resulting in abnormal secretion of extracellular matrix proteins and cytokines, leading to the deposition of type I collagen in the endometrium to form endometrial fibrosis [ 50 ].…”

Research progress of stem cell therapy for endometrial injury

“… Inhibits the cell viability of endometrial stromal cells, promotes G1 cell cycle arrest and apoptosis, and inhibits the synthesis and secretion of type I collagen. [ 168 ] Metformin Anti-diabetic drugs. Inhibits ER stress-induced apoptosis through PI3K/Akt and ERK1/2 pathways.…”